Pediatric Cancer Biomarkers Market Size, Share & Trends Report

Pediatric Cancer Biomarkers Market (2024 - 2030) Size, Share & Trends Analysis Report By Indication (Leukemia, Neuroblastoma, CNS Tumors, Lymphoma), By Biomarker (Alpha-fetoprotein, Neuron-specific enolase), By End Use, And Segment Forecasts

Market Segmentation

Pediatric Cancer Biomarkers Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Leukemia
- Neuroblastoma
- CNS Tumors
- Lymphoma
- Others
Pediatric Cancer Biomarkers Biomarker Outlook (Revenue, USD Million, 2018 - 2030)
- Alpha-fetoprotein (AFP)
- Neuron-specific enolase (NSE)
- CD19, CD20, CD22
- ALK (anaplastic lymphoma receptor tyrosine kinase gene)
- Others
Pediatric Cancer Biomarkers End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospital
- Diagnostic Laboratories
- Oncology Centers
- Research Institutions
Pediatric Cancer Biomarkers Market Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Pediatric Cancer Biomarkers Market, By Indication
    - Leukemia
    - Neuroblastoma
    - CNS Tumors
    - Lymphoma
    - Others
  - North America Pediatric Cancer Biomarkers Market, By Biomarker
    - Alpha-fetoprotein (AFP)
    - Neuron-specific enolase (NSE)
    - CD19, CD20, CD22
    - ALK (anaplastic lymphoma receptor tyrosine kinase gene)
    - Others
  - North America Pediatric Cancer Biomarkers Market, By End Use
    - Hospital
    - Diagnostic Laboratories
    - Oncology Centers
    - Research Institutions
  - U.S.
    - U.S. Pediatric Cancer Biomarkers Market, By Indication
      - Leukemia
      - Neuroblastoma
      - CNS Tumors
      - Lymphoma
      - Others
    - U.S. Pediatric Cancer Biomarkers Market, By Biomarker
      - Alpha-fetoprotein (AFP)
      - Neuron-specific enolase (NSE)
      - CD19, CD20, CD22
      - ALK (anaplastic lymphoma receptor tyrosine kinase gene)
      - Others
    - U.S. Pediatric Cancer Biomarkers Market, By End Use
      - Hospital
      - Diagnostic Laboratories
      - Oncology Centers
      - Research Institutions
  - Canada
    - Canada Pediatric Cancer Biomarkers Market, By Indication
      - Leukemia
      - Neuroblastoma
      - CNS Tumors
      - Lymphoma
      - Others
    - Canada Pediatric Cancer Biomarkers Market, By Biomarker
      - Alpha-fetoprotein (AFP)
      - Neuron-specific enolase (NSE)
      - CD19, CD20, CD22
      - ALK (anaplastic lymphoma receptor tyrosine kinase gene)
      - Others
    - Canada Pediatric Cancer Biomarkers Market, By End Use
      - Hospital
      - Diagnostic Laboratories
      - Oncology Centers
      - Research Institutions
  - Mexico
    - Mexico Pediatric Cancer Biomarkers Market, By Indication
      - Leukemia
      - Neuroblastoma
      - CNS Tumors
      - Lymphoma
      - Others
    - Mexico Pediatric Cancer Biomarkers Market, By Biomarker
      - Alpha-fetoprotein (AFP)
      - Neuron-specific enolase (NSE)
      - CD19, CD20, CD22
      - ALK (anaplastic lymphoma receptor tyrosine kinase gene)
      - Others
    - Mexico Pediatric Cancer Biomarkers Market, By End Use
      - Hospital
      - Diagnostic Laboratories
      - Oncology Centers
      - Research Institutions
- Europe
  - Europe Pediatric Cancer Biomarkers Market, By Indication
    - Leukemia
    - Neuroblastoma
    - CNS Tumors
    - Lymphoma
    - Others
  - Europe Pediatric Cancer Biomarkers Market, By Biomarker
    - Alpha-fetoprotein (AFP)
    - Neuron-specific enolase (NSE)
    - CD19, CD20, CD22
    - ALK (anaplastic lymphoma receptor tyrosine kinase gene)
    - Others
  - Europe Pediatric Cancer Biomarkers Market, By End Use
    - Hospital
    - Diagnostic Laboratories
    - Oncology Centers
    - Research Institutions
  - UK
    - UK Pediatric Cancer Biomarkers Market, By Indication
      - Leukemia
      - Neuroblastoma
      - CNS Tumors
      - Lymphoma
      - Others
    - UK Pediatric Cancer Biomarkers Market, By Biomarker
      - Alpha-fetoprotein (AFP)
      - Neuron-specific enolase (NSE)
      - CD19, CD20, CD22
      - ALK (anaplastic lymphoma receptor tyrosine kinase gene)
      - Others
    - UK Pediatric Cancer Biomarkers Market, By End Use
      - Hospital
      - Diagnostic Laboratories
      - Oncology Centers
      - Research Institutions
  - Germany
    - Germany Pediatric Cancer Biomarkers Market, By Indication
      - Leukemia
      - Neuroblastoma
      - CNS Tumors
      - Lymphoma
      - Others
    - Germany Pediatric Cancer Biomarkers Market, By Biomarker
      - Alpha-fetoprotein (AFP)
      - Neuron-specific enolase (NSE)
      - CD19, CD20, CD22
      - ALK (anaplastic lymphoma receptor tyrosine kinase gene)
      - Others
    - Germany Pediatric Cancer Biomarkers Market, By End Use
      - Hospital
      - Diagnostic Laboratories
      - Oncology Centers
      - Research Institutions
  - France
    - France Pediatric Cancer Biomarkers Market, By Indication
      - Leukemia
      - Neuroblastoma
      - CNS Tumors
      - Lymphoma
      - Others
    - France Pediatric Cancer Biomarkers Market, By Biomarker
      - Alpha-fetoprotein (AFP)
      - Neuron-specific enolase (NSE)
      - CD19, CD20, CD22
      - ALK (anaplastic lymphoma receptor tyrosine kinase gene)
      - Others
    - France Pediatric Cancer Biomarkers Market, By End Use
      - Hospital
      - Diagnostic Laboratories
      - Oncology Centers
      - Research Institutions
  - Italy
    - Italy Pediatric Cancer Biomarkers Market, By Indication
      - Leukemia
      - Neuroblastoma
      - CNS Tumors
      - Lymphoma
      - Others
    - Italy Pediatric Cancer Biomarkers Market, By Biomarker
      - Alpha-fetoprotein (AFP)
      - Neuron-specific enolase (NSE)
      - CD19, CD20, CD22
      - ALK (anaplastic lymphoma receptor tyrosine kinase gene)
      - Others
    - Italy Pediatric Cancer Biomarkers Market, By End Use
      - Hospital
      - Diagnostic Laboratories
      - Oncology Centers
      - Research Institutions
  - Spain
    - Spain Pediatric Cancer Biomarkers Market, By Indication
      - Leukemia
      - Neuroblastoma
      - CNS Tumors
      - Lymphoma
      - Others
    - Spain Pediatric Cancer Biomarkers Market, By Biomarker
      - Alpha-fetoprotein (AFP)
      - Neuron-specific enolase (NSE)
      - CD19, CD20, CD22
      - ALK (anaplastic lymphoma receptor tyrosine kinase gene)
      - Others
    - Spain Pediatric Cancer Biomarkers Market, By End Use
      - Hospital
      - Diagnostic Laboratories
      - Oncology Centers
      - Research Institutions
  - Denmark
    - Denmark Pediatric Cancer Biomarkers Market, By Indication
      - Leukemia
      - Neuroblastoma
      - CNS Tumors
      - Lymphoma
      - Others
    - Denmark Pediatric Cancer Biomarkers Market, By Biomarker
      - Alpha-fetoprotein (AFP)
      - Neuron-specific enolase (NSE)
      - CD19, CD20, CD22
      - ALK (anaplastic lymphoma receptor tyrosine kinase gene)
      - Others
    - Denmark Pediatric Cancer Biomarkers Market, By End Use
      - Hospital
      - Diagnostic Laboratories
      - Oncology Centers
      - Research Institutions
  - Sweden
    - Sweden Pediatric Cancer Biomarkers Market, By Indication
      - Leukemia
      - Neuroblastoma
      - CNS Tumors
      - Lymphoma
      - Others
    - Sweden Pediatric Cancer Biomarkers Market, By Biomarker
      - Alpha-fetoprotein (AFP)
      - Neuron-specific enolase (NSE)
      - CD19, CD20, CD22
      - ALK (anaplastic lymphoma receptor tyrosine kinase gene)
      - Others
    - Sweden Pediatric Cancer Biomarkers Market, By End Use
      - Hospital
      - Diagnostic Laboratories
      - Oncology Centers
      - Research Institutions
  - Norway
    - Norway Pediatric Cancer Biomarkers Market, By Indication
      - Leukemia
      - Neuroblastoma
      - CNS Tumors
      - Lymphoma
      - Others
    - Norway Pediatric Cancer Biomarkers Market, By Biomarker
      - Alpha-fetoprotein (AFP)
      - Neuron-specific enolase (NSE)
      - CD19, CD20, CD22
      - ALK (anaplastic lymphoma receptor tyrosine kinase gene)
      - Others
    - Norway Pediatric Cancer Biomarkers Market, By End Use
      - Hospital
      - Diagnostic Laboratories
      - Oncology Centers
      - Research Institutions
- Asia Pacific
  - Asia Pacific Pediatric Cancer Biomarkers Market, By Indication
    - Leukemia
    - Neuroblastoma
    - CNS Tumors
    - Lymphoma
    - Others
  - Asia Pacific Pediatric Cancer Biomarkers Market, By Biomarker
    - Alpha-fetoprotein (AFP)
    - Neuron-specific enolase (NSE)
    - CD19, CD20, CD22
    - ALK (anaplastic lymphoma receptor tyrosine kinase gene)
    - Others
  - Asia Pacific Pediatric Cancer Biomarkers Market, By End Use
    - Hospital
    - Diagnostic Laboratories
    - Oncology Centers
    - Research Institutions
  - Japan
    - Japan Pediatric Cancer Biomarkers Market, By Indication
      - Leukemia
      - Neuroblastoma
      - CNS Tumors
      - Lymphoma
      - Others
    - Japan Pediatric Cancer Biomarkers Market, By Biomarker
      - Alpha-fetoprotein (AFP)
      - Neuron-specific enolase (NSE)
      - CD19, CD20, CD22
      - ALK (anaplastic lymphoma receptor tyrosine kinase gene)
      - Others
    - Japan Pediatric Cancer Biomarkers Market, By End Use
      - Hospital
      - Diagnostic Laboratories
      - Oncology Centers
      - Research Institutions
  - China
    - China Pediatric Cancer Biomarkers Market, By Indication
      - Leukemia
      - Neuroblastoma
      - CNS Tumors
      - Lymphoma
      - Others
    - China Pediatric Cancer Biomarkers Market, By Biomarker
      - Alpha-fetoprotein (AFP)
      - Neuron-specific enolase (NSE)
      - CD19, CD20, CD22
      - ALK (anaplastic lymphoma receptor tyrosine kinase gene)
      - Others
    - China Pediatric Cancer Biomarkers Market, By End Use
      - Hospital
      - Diagnostic Laboratories
      - Oncology Centers
      - Research Institutions
  - India
    - India Pediatric Cancer Biomarkers Market, By Indication
      - Leukemia
      - Neuroblastoma
      - CNS Tumors
      - Lymphoma
      - Others
    - India Pediatric Cancer Biomarkers Market, By Biomarker
      - Alpha-fetoprotein (AFP)
      - Neuron-specific enolase (NSE)
      - CD19, CD20, CD22
      - ALK (anaplastic lymphoma receptor tyrosine kinase gene)
      - Others
    - India Pediatric Cancer Biomarkers Market, By End Use
      - Hospital
      - Diagnostic Laboratories
      - Oncology Centers
      - Research Institutions
  - Australia
    - Australia Pediatric Cancer Biomarkers Market, By Indication
      - Leukemia
      - Neuroblastoma
      - CNS Tumors
      - Lymphoma
      - Others
    - Australia Pediatric Cancer Biomarkers Market, By Biomarker
      - Alpha-fetoprotein (AFP)
      - Neuron-specific enolase (NSE)
      - CD19, CD20, CD22
      - ALK (anaplastic lymphoma receptor tyrosine kinase gene)
      - Others
    - Australia Pediatric Cancer Biomarkers Market, By End Use
      - Hospital
      - Diagnostic Laboratories
      - Oncology Centers
      - Research Institutions
  - South Korea
    - South Korea Pediatric Cancer Biomarkers Market, By Indication
      - Leukemia
      - Neuroblastoma
      - CNS Tumors
      - Lymphoma
      - Others
    - South Korea Pediatric Cancer Biomarkers Market, By Biomarker
      - Alpha-fetoprotein (AFP)
      - Neuron-specific enolase (NSE)
      - CD19, CD20, CD22
      - ALK (anaplastic lymphoma receptor tyrosine kinase gene)
      - Others
    - South Korea Pediatric Cancer Biomarkers Market, By End Use
      - Hospital
      - Diagnostic Laboratories
      - Oncology Centers
      - Research Institutions
  - Thailand
    - Thailand Pediatric Cancer Biomarkers Market, By Indication
      - Leukemia
      - Neuroblastoma
      - CNS Tumors
      - Lymphoma
      - Others
    - Thailand Pediatric Cancer Biomarkers Market, By Biomarker
      - Alpha-fetoprotein (AFP)
      - Neuron-specific enolase (NSE)
      - CD19, CD20, CD22
      - ALK (anaplastic lymphoma receptor tyrosine kinase gene)
      - Others
    - Thailand Pediatric Cancer Biomarkers Market, By End Use
      - Hospital
      - Diagnostic Laboratories
      - Oncology Centers
      - Research Institutions
- Latin America
  - Latin America Pediatric Cancer Biomarkers Market, By Indication
    - Leukemia
    - Neuroblastoma
    - CNS Tumors
    - Lymphoma
    - Others
  - Latin America Pediatric Cancer Biomarkers Market, By Biomarker
    - Alpha-fetoprotein (AFP)
    - Neuron-specific enolase (NSE)
    - CD19, CD20, CD22
    - ALK (anaplastic lymphoma receptor tyrosine kinase gene)
    - Others
  - Latin America Pediatric Cancer Biomarkers Market, By End Use
    - Hospital
    - Diagnostic Laboratories
    - Oncology Centers
    - Research Institutions
  - Brazil
    - Brazil Pediatric Cancer Biomarkers Market, By Indication
      - Leukemia
      - Neuroblastoma
      - CNS Tumors
      - Lymphoma
      - Others
    - Brazil Pediatric Cancer Biomarkers Market, By Biomarker
      - Alpha-fetoprotein (AFP)
      - Neuron-specific enolase (NSE)
      - CD19, CD20, CD22
      - ALK (anaplastic lymphoma receptor tyrosine kinase gene)
      - Others
    - Brazil Pediatric Cancer Biomarkers Market, By End Use
      - Hospital
      - Diagnostic Laboratories
      - Oncology Centers
      - Research Institutions
  - Argentina
    - Argentina Pediatric Cancer Biomarkers Market, By Indication
      - Leukemia
      - Neuroblastoma
      - CNS Tumors
      - Lymphoma
      - Others
    - Argentina Pediatric Cancer Biomarkers Market, By Biomarker
      - Alpha-fetoprotein (AFP)
      - Neuron-specific enolase (NSE)
      - CD19, CD20, CD22
      - ALK (anaplastic lymphoma receptor tyrosine kinase gene)
      - Others
    - Argentina Pediatric Cancer Biomarkers Market, By End Use
      - Hospital
      - Diagnostic Laboratories
      - Oncology Centers
      - Research Institutions
- Middle East & Africa
  - Middle East & Africa Pediatric Cancer Biomarkers Market, By Indication
    - Leukemia
    - Neuroblastoma
    - CNS Tumors
    - Lymphoma
    - Others
  - Middle East & Africa Pediatric Cancer Biomarkers Market, By Biomarker
    - Alpha-fetoprotein (AFP)
    - Neuron-specific enolase (NSE)
    - CD19, CD20, CD22
    - ALK (anaplastic lymphoma receptor tyrosine kinase gene)
    - Others
  - Middle East & Africa Pediatric Cancer Biomarkers Market, By End Use
    - Hospital
    - Diagnostic Laboratories
    - Oncology Centers
    - Research Institutions
  - South Africa
    - South Africa Pediatric Cancer Biomarkers Market, By Indication
      - Leukemia
      - Neuroblastoma
      - CNS Tumors
      - Lymphoma
      - Others
    - South Africa Pediatric Cancer Biomarkers Market, By Biomarker
      - Alpha-fetoprotein (AFP)
      - Neuron-specific enolase (NSE)
      - CD19, CD20, CD22
      - ALK (anaplastic lymphoma receptor tyrosine kinase gene)
      - Others
    - South Africa Pediatric Cancer Biomarkers Market, By End Use
      - Hospital
      - Diagnostic Laboratories
      - Oncology Centers
      - Research Institutions
  - Saudi Arabia
    - Saudi Arabia Pediatric Cancer Biomarkers Market, By Indication
      - Leukemia
      - Neuroblastoma
      - CNS Tumors
      - Lymphoma
      - Others
    - Saudi Arabia Pediatric Cancer Biomarkers Market, By Biomarker
      - Alpha-fetoprotein (AFP)
      - Neuron-specific enolase (NSE)
      - CD19, CD20, CD22
      - ALK (anaplastic lymphoma receptor tyrosine kinase gene)
      - Others
    - Saudi Arabia Pediatric Cancer Biomarkers Market, By End Use
      - Hospital
      - Diagnostic Laboratories
      - Oncology Centers
      - Research Institutions
  - UAE
    - UAE Pediatric Cancer Biomarkers Market, By Indication
      - Leukemia
      - Neuroblastoma
      - CNS Tumors
      - Lymphoma
      - Others
    - UAE Pediatric Cancer Biomarkers Market, By Biomarker
      - Alpha-fetoprotein (AFP)
      - Neuron-specific enolase (NSE)
      - CD19, CD20, CD22
      - ALK (anaplastic lymphoma receptor tyrosine kinase gene)
      - Others
    - UAE Pediatric Cancer Biomarkers Market, By End Use
      - Hospital
      - Diagnostic Laboratories
      - Oncology Centers
      - Research Institutions
  - Kuwait
    - Kuwait Pediatric Cancer Biomarkers Market, By Indication
      - Leukemia
      - Neuroblastoma
      - CNS Tumors
      - Lymphoma
      - Others
    - Kuwait Pediatric Cancer Biomarkers Market, By Biomarker
      - Alpha-fetoprotein (AFP)
      - Neuron-specific enolase (NSE)
      - CD19, CD20, CD22
      - ALK (anaplastic lymphoma receptor tyrosine kinase gene)
      - Others
    - Kuwait Pediatric Cancer Biomarkers Market, By End Use
      - Hospital
      - Diagnostic Laboratories
      - Oncology Centers
      - Research Institutions

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments